Literature DB >> 3036083

The vasoactive intestinal peptide receptor on intact human colonic adenocarcinoma cells (HT29-D4). Evidence for its glycoprotein nature.

A el Battari, J Luis, J M Martin, J Fantini, J M Muller, J Marvaldi, J Pichon.   

Abstract

We have previously shown that the mono [125I]iodinated vasoactive intestinal peptide (125I-VIP) could be covalently cross-linked on intact colonic adenocarcinoma cells (HT29). A major Mr 67,000 and a minor Mr 120,000 cross-linked polypeptides have been characterized [Muller, Luis, Fantini, Abadie, Giannellini, Marvaldi & Pichon (1985) Eur. J. Biochem. 151, 411-417]. The glycoprotein nature of these species was investigated using endo-beta-acetylglucosaminidase F (Endo F) treatment, enzymic and chemical desialylation and wheat germ agglutinin (WGA)-Sepharose affinity chromatography. Affinity-labelled VIP-binding proteins solubilized by Nonidet P-40 bound to WGA-Sepharose and could be eluted specifically with N-acetyl-D-glucosamine. Treatment with Endo F resulted in an increased electrophoretic mobility of both polypeptides. The major and the minor VIP-binding proteins were converted respectively into Mr 47,000 and 100,000 species, indicating removal of 20 kDa of N-linked oligosaccharides. Deglycosylation with trifluoromethanesulphonic acid also led to a 20 kDa loss in mass of the Mr 67,000 component, indicating the absence of additional O-linked sugars on this polypeptide. The presence of sialic acid on the major VIP-binding protein was demonstrated after treatment of intact cells with neuraminidase or by chemical desialylation with hydrochloric acid. We conclude from this study that the VIP receptor from intact HT29-D4 cells is a glycoprotein with N-linked oligosaccharide side chains containing sialic acid.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3036083      PMCID: PMC1147681          DOI: 10.1042/bj2420185

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

Review 1.  Characterization of sialic acids.

Authors:  R Schauer
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

2.  The human vasoactive intestinal peptide receptor: molecular identification by covalent cross-linking in colonic epithelium.

Authors:  A Couvineau; M Laburthe
Journal:  J Clin Endocrinol Metab       Date:  1985-07       Impact factor: 5.958

3.  Covalent cross-linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29).

Authors:  J M Muller; J Luis; J Fantini; B Abadie; F Giannellini; J Marvaldi; J Pichon
Journal:  Eur J Biochem       Date:  1985-09-02

4.  Sialic acid in human cancer.

Authors:  E W Mabry; R Carubelli
Journal:  Experientia       Date:  1972-02-15

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Deglycosylation of glycoproteins by trifluoromethanesulfonic acid.

Authors:  A S Edge; C R Faltynek; L Hof; L E Reichert; P Weber
Journal:  Anal Biochem       Date:  1981-11-15       Impact factor: 3.365

7.  endo-beta-N-acetylglucosaminidase F: endoglycosidase from Flavobacterium meningosepticum that cleaves both high-mannose and complex glycoproteins.

Authors:  J H Elder; S Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

8.  Covalent cross-linking of vasoactive intestinal polypeptide to its receptors on intact human lymphoblasts.

Authors:  C L Wood; M S O'Dorisio
Journal:  J Biol Chem       Date:  1985-01-25       Impact factor: 5.157

9.  The hepatic glucagon receptor. Solubilization, characterization, and development of an affinity adsorption assay for the soluble receptor.

Authors:  J T Herberg; J Codina; K A Rich; F J Rojas; R Iyengar
Journal:  J Biol Chem       Date:  1984-07-25       Impact factor: 5.157

10.  Spontaneous and induced dome formation by two clonal cell populations derived from a human adenocarcinoma cell line, HT29.

Authors:  J Fantini; B Abadie; A Tirard; L Remy; J P Ripert; A el Battari; J Marvaldi
Journal:  J Cell Sci       Date:  1986-07       Impact factor: 5.285

View more
  2 in total

1.  Photoaffinity labelling of the vasoactive-intestinal-peptide-binding site on intact human colonic adenocarcinoma cell line HT29-D4. Synthesis and use of photosensitive vasoactive-intestinal-peptide derivatives.

Authors:  J M Martin; H Darbon; J Luis; A el Battari; J Marvaldi; J Pichon
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

2.  Effect of inhibiting N-glycosylation or oligosaccharide processing on vasoactive intestinal peptide receptor binding activity and structure.

Authors:  A el Battari; P Forget; F Fouchier; P Pic
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.